06622.HK
Zhaoke Ophthalmology Limited
HKSE · Healthcare · Biotechnology · CN
HKD 2.53
+1.61%Aug 12, 2026, 09:02 UTC
Zhaoke Ophthalmology signed an exclusive distribution and promotion agreement with Pengpai Biomedical for its epinastine hydrochloride eye drops (brand: Mingyanshu) covering all sales channels in mainland China, with an initial five-year term and possible extension to ten years.
Source: